Intrinsic Value of S&P & Nasdaq Contact Us

Eton Pharmaceuticals, Inc. ETON NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
$381.58
+1307%
Analyst Price Target
$25.00
-7.8%

Stock Statistics — ETON

Eton Pharmaceuticals, Inc. (ETON) has a market capitalization of $739.96M and trades at $27.12. The 52-week range is 11.09-25.99.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -159.5, Earnings Per Share (EPS) of $-0.17, annual revenue of $79.95M.

The stock has a beta of 0.97, operates in the Healthcare sector.

Trading Data
Current Price$27.12
52-Week Range11.09-25.99
Volume261.1K
Avg Volume (30D)349.99K
Market Cap$739.96M
Beta (1Y)0.97
Company
IPO Date2018-11-13
Employees31
CEOSean E. Brynjelsen
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS29772L1089
CUSIP29772L108
Income (Latest Year)
Revenue$79.95M
Gross Profit$42.74M
EBITDA$4.12M
Operating Income$72K
Net Income$-4.6M
EPS$-0.17
EPS Diluted$-0.17
Shares Outstanding$26.91M
Balance Sheet (Latest Year)
Total Assets$92.11M
Current Assets$60.58M
Cash & ST Investments$25.94M
Total Liabilities$65.96M
Total Debt$31.02M
Net Debt$5.08M
Total Equity$26.15M
Debt / Equity1.19
Valuation Ratios
P/E Ratio-159.5
P/S Ratio9.26
P/B Ratio28.29
EV/EBITDA (approx)179.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message